A short overview of resistance to approved histone deacetylase inhibitors
Author:
Affiliation:
1. Institut für Pharmazeutische und Medizinische Chemie, Heinrich-Heine-Universität Düsseldorf, Universitätsstr. 1, Düsseldorf, 40225, Germany
Funder
Patient-Deutsche Forschungsgemeinschaft
Publisher
Future Science Ltd
Subject
Drug Discovery,Pharmacology,Molecular Medicine
Link
https://www.future-science.com/doi/pdf/10.4155/fmc-2021-0102
Reference18 articles.
1. Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight
2. Development of chidamide for peripheral T-cell lymphoma, the first orphan drug approved in China
3. Synergistic Enhancement of Cancer Therapy Using HDAC Inhibitors: Opportunity for Clinical Trials
4. Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The Roles of Histone Deacetylases in the Regulation of Ovarian Cancer Metastasis;International Journal of Molecular Sciences;2023-10-11
2. HDACIs and TKIs combinations and their liposomal delivery for cancer treatment;Journal of Controlled Release;2023-06
3. Metformin exerts antileukemic effects by modulating lactate metabolism and overcomes imatinib resistance in chronic myelogenous leukemia;The FEBS Journal;2023-05-23
4. Retinoic acid and evernyl-based menadione-triazole hybrid cooperate to induce differentiation of neuroblastoma cells;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-04-25
5. Current trends in development of HDAC-based chemotherapeutics;Life Sciences;2022-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3